Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RLAY is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
49 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 6 days ago
Red flags: 2
260 filers reported a long position in RLAY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | $522.1M | 27.9M | Unchanged |
| FMR LLC | $376.3M | 20.1M | +444.2% |
| Casdin Capital, LLC | $300M | 16M | +11.2% |
| BlackRock, Inc. | $286M | 15.3M | +17.8% |
| PERCEPTIVE ADVISORS LLC | $263.9M | 14.1M | +44.7% |
| Commodore Capital LP | $224.5M | 12M | -29.4% |
| STATE STREET CORP | $189.5M | 10.1M | +62.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $167.7M | 9M | +21.3% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $144.2M | 7.7M | +300.5% |
| Nextech Invest Ltd. | $126.8M | 6.8M | +22.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.